Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real-world-effectiveness of biological treatment for severe chronic rhinosinusitis with nasal polyps
Boris Haxel, Thomas Hummel, Kai Fruth, et al.
Rhinology Journal (2022)
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Position paper on olfactory dysfunction: 2023
Katherine L. Whitcroft, Aytuğ Altundağ, Patrick Balungwe, et al.
Rhinology Journal (2023) Vol. 61, Iss. 33, pp. 1-131
Open Access | Times Cited: 73
Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months
Rik Johannes Leonardus van der Lans, Josje Janna Otten, Gwijde Flavius Jacobus Petrus Maria Adriaensen, et al.
Allergy (2023) Vol. 78, Iss. 10, pp. 2684-2697
Open Access | Times Cited: 39
Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy
Tobias Albrecht, Martin M. Sailer, Flavia Capitani, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 5, pp. 100780-100780
Open Access | Times Cited: 23
Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy
Antonino Maniaci, Alberto Maria Saibene, Christian Calvo‐Henríquez, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 281, Iss. 4, pp. 2167-2173
Closed Access | Times Cited: 11
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
F Fujieda, Chenwei Wang, Mamoru Yoshikawa, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 10
Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access | Times Cited: 1
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care
Peter W. Hellings, Isam Alobid, Wilma Terezinha Anselmo‐Lima, et al.
Allergy (2023) Vol. 79, Iss. 5, pp. 1123-1133
Open Access | Times Cited: 21
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
Patrick Huber, Ulrike Förster‐Ruhrmann, Heidi Olze, et al.
Allergy (2024) Vol. 79, Iss. 11, pp. 3108-3117
Open Access | Times Cited: 6
Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study
Ignazio La Mantia, Egle Grigaliute, Martina Ragusa, et al.
European Archives of Oto-Rhino-Laryngology (2023) Vol. 281, Iss. 1, pp. 219-226
Closed Access | Times Cited: 13
Dupilumab’s Impact on Blood Parameters in Nasal Polyposis: 18-Month Follow-Up in Real Life
Antonella Loperfido, Andrea Ciofalo, Carlo Cavaliere, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 13
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps
Marco Caminati, Eugenio De Corso, Giancarlo Ottaviano, et al.
Current Allergy and Asthma Reports (2023) Vol. 24, Iss. 1, pp. 11-23
Open Access | Times Cited: 13
Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update
Wilma Terezinha Anselmo‐Lima, Fabrizio Ricci Romano, Edwin Tamashiro, et al.
Brazilian Journal of Otorhinolaryngology (2024) Vol. 90, Iss. 3, pp. 101394-101394
Open Access | Times Cited: 5
Biologikatherapie bei schwer erkrankten Patienten mit „NSAID-exacerbated respiratory disease“ und stattgehabter ASS‑Desaktivierung
Anna-Rebekka Staufenberg, H. Frankenberger, Ulrike Förster‐Ruhrmann, et al.
HNO (2024) Vol. 72, Iss. 7, pp. 473-483
Open Access | Times Cited: 5
Comparing Medical and Surgical Management of Chronic Rhinosinusitis: A Systematic Review of Dupilumab and Endoscopic Sinus Surgery
Barbara N. Weissman, Kevin Shen, Oisin Flanagan, et al.
Cureus (2025)
Open Access
Diagnostik und medikamentöse Therapie der chronischen Rhinosinusitis
Sven Becker
HNO (2025)
Open Access
Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center
Reut Book, Shalom Eligal, Yuval Tal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 11, pp. 3671-3671
Open Access | Times Cited: 10
Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes
Isaac L. Schmale, Alexander Poulakis, Audrey Abend, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 10, pp. 3203-3210
Closed Access | Times Cited: 9
Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts
Angela Rizzi, Luca Gammeri, Raffaele Cordiano, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 8, pp. 2841-2841
Open Access | Times Cited: 7
Real Life Observational Study of Treatment Success of Monoclonal Antibodies for Refractory Chronic Rhinosinusitis with Nasal Polyps
Kathrin Gerstacker, Manuel Christoph Ketterer, Till F. Jakob, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4374-4374
Open Access | Times Cited: 6
Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
Glenis Scadding, Claudia L. Gray, Diego M. Conti, et al.
Frontiers in Allergy (2024) Vol. 5
Open Access | Times Cited: 2
Efficacy of different biologics for treating chronic rhinosinusitis with nasal polyps: a network meta-analysis
Huikang Wang, Xinjun Xu, Zhaoyang Lu, et al.
European Archives of Oto-Rhino-Laryngology (2024) Vol. 282, Iss. 2, pp. 559-569
Closed Access | Times Cited: 2
Clinical Effects and Response Time of Biological Drugs in Chronic Rhinosinusitis with Nasal Polyps Patients: Real‐life Experience
S. De Santis, Stefania Galassi, Jacopo Cambi
The Laryngoscope (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top